Proteomic analysis identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer.
about
The associations between Parkinson's disease and cancer: the plot thickensSystems biology of cisplatin resistance: past, present and futureDJ-1-dependent regulation of oxidative stress in the retinal pigment epithelium (RPE)Mechanistic Nanotherapeutic Approach Based on siRNA-Mediated DJ-1 Protein Suppression for Platinum-Resistant Ovarian CancerStrategies for discovering novel pancreatic cancer biomarkers.The evidence of HeLa cell apoptosis induced with tetraethylammonium using proteomics and various analytical methods.Quantum-dot-based suspension microarray for multiplex detection of lung cancer markers: preclinical validation and comparison with the Luminex xMAP® systemIdentification of DJ-1 as a contributor to multidrug resistance in human small-cell lung cancer using proteomic analysis.Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance.DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer.Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references.DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients.Biological and Clinical Implications of Comorbidities in Parkinson's Disease.Expression of DJ-1 in Cancer Cells: Its Correlation with Clinical Significance.Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.DJ-1 as a Therapeutic Target Against Cancer.Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin.Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach.
P2860
Q26778641-675AFC4D-ED32-4A99-BAB2-B794C07137A3Q26863585-2AC91257-B303-4A53-B94A-E564E1B8D56EQ28534455-B5A0D029-BEC1-4CC2-8550-297EAEAA9E30Q29247912-43F04750-E3FD-40B8-B112-DED0BD9104B2Q36579311-5E1A95D5-F9A8-4770-AF72-0C0656B1D873Q37511746-B48AAC56-A23F-40B5-A0AE-204230E87693Q37704761-111E2983-B901-442C-9B5E-D4F545AB94CAQ38701271-146D5D01-FE61-4943-A42F-5C5AEE1B87C0Q38798223-5CC5A03C-D9DD-4C34-AD5F-7C56F0AF6E95Q39360474-0DFB8C11-AB07-43DD-9618-449FA1865224Q41428743-B9D66BB2-92F8-4E1C-A3F5-D793C896E8C3Q42290338-74212AEF-AE5B-468C-B32E-9E76ECF8AC74Q43818230-3941358E-A97D-46F2-BD39-D58310E82BA0Q47137783-CF937D08-FA23-461A-BADC-584DD27D9858Q47393151-1AC26923-A28B-4EF1-89EE-8204F44FFD69Q48955308-16B67A2A-1C49-47B0-82A8-78FC738C5D8AQ49936710-248F8BD5-5AF4-42BA-8C85-57EEF2BE6437Q52596252-7D41E1BA-98FB-48AB-8B3B-09A3D963D010Q54259614-251D917D-804E-4F62-9A6F-0AB3105B94A4
P2860
Proteomic analysis identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Proteomic analysis identified ...... in non-small cell lung cancer.
@ast
Proteomic analysis identified ...... in non-small cell lung cancer.
@en
type
label
Proteomic analysis identified ...... in non-small cell lung cancer.
@ast
Proteomic analysis identified ...... in non-small cell lung cancer.
@en
prefLabel
Proteomic analysis identified ...... in non-small cell lung cancer.
@ast
Proteomic analysis identified ...... in non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
Proteomic analysis identified ...... in non-small cell lung cancer.
@en
P2093
Ai-Bin Liang
An-Mei Deng
Hua-Zong Zeng
Wen-Jun Zhang
Yi-Qing Qu
P2860
P304
P356
10.3390/IJMS12063489
P407
P577
2011-06-01T00:00:00Z